Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by Oncogenic <i>K-ras</i>

Abstract The serine/threonine kinase AKT and its downstream mediator mammalian target of rapamycin (mTOR) are activated in lung adenocarcinoma, and clinical trials are under way to test whether inhibition of mTOR is useful in treating lung cancer. Here, we report that mTOR inhibition blocked maligna...

Бүрэн тодорхойлолт

-д хадгалсан:
Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Marie Wislez, M. Loreto Spencer, Julie Izzo, Denise M. Juroske, Kamna S. Balhara, Dianna D. Cody, Roger E. Price, Walter N. Hittelman, Ignacio I. Wistuba, Jonathan M. Kurie
Формат: Artigo
Хэл сонгох:англи
Хэвлэсэн: 2005
Онлайн хандалт:https://doi.org/10.1158/0008-5472.can-04-4420
https://aacrjournals.org/cancerres/article-pdf/65/8/3226/2542217/3226-3235.pdf
Шошгууд: Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!